Mental & Behavioral Health
Caring for the mind
This paper explores considerations for state agencies involved with Medicaid, health, and insurance that are considering the updated ASAM Criteria and potential future changes.
Appropriate clinical supervision and prescription management may help mitigate the overdose risks associated with psychotropics or select CNS medications.
This paper studies the prevalence of mental health and substance use disorders within commercially insured families in the United States.
In 2024, employee well-being remains the most important reason employers offer mental health resources, according to our latest Pulse Survey.
Appropriate clinical supervision and prescription management may help mitigate the overdose risks associated with psychotropics or select CNS medications.
The COVID-19 pandemic has caused rates of anxiety and depression to surge. Left untreated, these conditions may contribute to serious physical illness and impede the ability of people to perform at work.
Telehealth visits may become part of the new “normal” for replacing, or at least supplementing, office visit-based treatment for behavioral health conditions.
In this podcast, Milliman experts discuss the range of mental health and substance use issues sparked-or made worse-by the pandemic, how different populations are being affected, and the rising demand for mental health services.
What has happened to utilization and costs for mental health and substance use disorder benefits as the mental health parity laws and associated rules were slowly rolled out?
